EORTC Extends Medidata Partnership to Help Power New Phase of Oncology Research
September 11 2024 - 3:00AM
Business Wire
Medidata technology deployed to increase
access to and transform the patient experience for cancer
trials
Medidata, a Dassault Systèmes brand and leading provider of
clinical trial solutions to the life sciences industry, and the
European Organisation for Research and Treatment of Cancer (EORTC),
announced today a four-year extension to their partnership. The
extended relationship will enable EORTC to further increase patient
access to oncology clinical trials, make trial participation
easier, and help to deliver new treatments to the market faster.
EORTC is now leveraging 13 Medidata solutions, enabling their
researchers to access and manage all clinical data in a single
place and offering patients a seamless trial experience.
Vassilis Golfinopoulos, headquarters director, EORTC, said, “We
chose the Medidata Platform to further expand our data management
and patient engagement capabilities based on our years of
experience working together. This partnership will enhance our
support for oncology researchers as we collaborate on innovative
ways of working with clinical trial data in the future.”
“This expansion benefits patients through an improved clinical
trial experience, engaging with study activities on their personal
mobile devices, while researchers will have the ability to make
better decisions faster,” said Janet Butler, executive vice
president, head of global sales, Medidata. “The integration of
additional solutions, including Medidata Rave CTMS and Medidata
Rave eTMF, will empower EORTC researchers with higher data quality,
allowing them to shorten study timelines and deliver safer oncology
trials for patients.”
For EORTC the expanded partnership also allows the exploration
of a joint research and data collaboration with Medidata AI
solutions in pursuit of improved standards of cancer care.
About Medidata
Medidata is powering smarter treatments and healthier people
through digital solutions to support clinical trials. Celebrating
25 years of ground-breaking technological innovation across more
than 34,000 trials and 10 million patients, Medidata offers
industry-leading expertise, analytics-powered insights, and the
largest patient-level historical clinical trial data set in the
world. More than 1 million registered users across approximately
2,200 customers trust Medidata’s seamless, end-to-end platform to
improve patient experiences, accelerate clinical breakthroughs, and
bring therapies to market faster. A Dassault Systèmes brand
(Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered
in New York City and has been recognized as a Leader by Everest
Group and IDC. Discover more at www.medidata.com and follow us
@Medidata.
About Dassault Systèmes
Dassault Systèmes is a catalyst for human progress. We provide
business and people with collaborative virtual environments to
imagine sustainable innovations. By creating virtual twin
experiences of the real world with our 3DEXPERIENCE platform and
applications, our customers can redefine the creation, production
and life-cycle-management processes of their offer and thus have a
meaningful impact to make the world more sustainable. The beauty of
the Experience Economy is that it is a human-centered economy for
the benefit of all – consumers, patients and citizens. Dassault
Systèmes brings value to more than 350,000 customers of all sizes,
in all industries, in more than 150 countries. For more
information, visit www.3ds.com
© Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS
logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA,
CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE,
SIMULIA and SOLIDWORKS are commercial trademarks or registered
trademarks of Dassault Systèmes, a European company (Societas
Europaea) incorporated under French law, and registered with the
Versailles trade and companies registry under number 322 306 440,
or its subsidiaries in the United States and/or other countries.
All other trademarks are owned by their respective owners. Use of
any Dassault Systèmes or its subsidiaries trademarks is subject to
their express written approval.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240911258262/en/
Medidata PR Medidata.PR@3ds.com
Analyst Relations Medidata.AR@3ds.com
Big Tree Cloud (NASDAQ:DSY)
Historical Stock Chart
From Sep 2024 to Oct 2024
Big Tree Cloud (NASDAQ:DSY)
Historical Stock Chart
From Oct 2023 to Oct 2024